Fumito Tamura
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study.
Journal: Japanese journal of clinical oncology
Published: June 15, 2023
Clinical factors associated with acute abdominal symptoms induced by gastric anisakiasis: a multicenter retrospective cohort study.
Journal: BMC gastroenterology
Published: May 29, 2023
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report.
Journal: Frontiers in immunology
Published: April 11, 2023
Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer.
Journal: Frontiers in oncology
Published: April 10, 2023
Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib.
Journal: Internal medicine (Tokyo, Japan)
Published: March 29, 2019
CapeOX Therapy as a Salvage Treatment for Advanced Gastric Cancer Refractory to S-1, Cisplatin, Irinotecan, and Taxanes
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 20, 2018
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 30, 2016
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: February 11, 2015
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: February 11, 2015
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: August 13, 2014
Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer.
Journal: Targeted oncology
Published: January 02, 2014
Last Updated: 09/26/2026